
Global Blood Therapeutics GBT
Quarterly report 2022-Q2
added 08-08-2022
Global Blood Therapeutics Total Inventories 2011-2026 | GBT
Annual Total Inventories Global Blood Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 58.2 M | 40.2 M | 1.28 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.2 M | 1.28 M | 33.2 M |
Quarterly Total Inventories Global Blood Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 65.8 M | 62 M | 58.2 M | 51.5 M | 48 M | 42.3 M | 40.2 M | 40.2 M | 40.2 M | 40.2 M | 1.28 M | 1.28 M | 1.28 M | 1.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 65.8 M | 1.28 M | 35.3 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.82 | 1.9 % | $ 4.47 M | ||
|
Aquestive Therapeutics
AQST
|
6.04 M | $ 4.18 | 2.32 % | $ 363 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 165.2 | -2.79 % | $ 8.22 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
2.17 B | $ 190.58 | -2.33 % | $ 27.9 B | ||
|
BioMarin Pharmaceutical
BMRN
|
1.23 B | $ 61.56 | -1.7 % | $ 11.7 B | ||
|
Baudax Bio
BXRX
|
5 M | - | 0.59 % | $ 63 K | ||
|
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.68 | 0.1 % | $ 4.54 B | ||
|
CASI Pharmaceuticals
CASI
|
1.91 M | $ 0.35 | -55.89 % | $ 47.6 M |